Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 07/31/06
Due: 07/31/07
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 05/31/09
Due: 05/31/10
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2) | NCT00303550 | Arpida AG | user2@example.com | None | 2006-03-31 | - | - | - | - | 2025-07-14 |
| Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1) | NCT00299520 | Arpida AG | user2@example.com | None | 2005-06-30 | 2006-07-31 | 2007-07-31 | - | - | 2025-07-14 |
| Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia | NCT00543608 | Arpida AG | user2@example.com | None | 2007-11-30 | 2009-05-31 | 2010-05-31 | - | - | 2025-07-14 |